Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).

Identifieur interne : 004905 ( Main/Exploration ); précédent : 004904; suivant : 004906

Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).

Auteurs : Szu-Chia Lai [Taïwan] ; Pele Choi-Sing Chong ; Chia-Tsui Yeh ; Levent Shih-Jen Liu ; Jia-Tsrong Jan ; Hsiang-Yun Chi ; Hwan-Wun Liu ; Ann Chen ; Yeau-Ching Wang

Source :

RBID : pubmed:16132115

Descripteurs français

English descriptors

Abstract

The spike (S) glycoprotein is thought to play a complex and central role in the biology and pathogenesis of SARS coronavirus infection. In this study, a recombinant protein (rS268, corresponding to residues 268-1255 of SARS-CoV S protein) was expressed in Escherichia coli and was purified to near homogeneity. After immunization with rS268, S protein-specific BALB/c antisera and mAbs were induced and confirmed using ELISA, Western blot and IFA. Several BALB/c mAbs were found to be effectively to neutralize the infection of Vero E6 cells by SARS-CoV in a dose-dependent manner. Systematic epitope mapping showed that all these neutralizing mAbs recognized a 15-residues peptide (CB-119) corresponding to residues 1143-1157 (SPDVDLGDISGINAS) that was located to the second heptad repeat (HR2) region of the SARS-CoV spike protein. The peptide CB-119 could specifically inhibit the interaction of neutralizing mAbs and spike protein in a dose-dependent manner. Further, neutralizing mAbs, but not control mAbs, could specifically interact with CB-119 in a dose-dependent manner. Results implicated that the second heptad repeat region of spike protein could be a good target for vaccine development against SARS-CoV.

DOI: 10.1007/s11373-005-9004-3
PubMed: 16132115


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).</title>
<author>
<name sortKey="Lai, Szu Chia" sort="Lai, Szu Chia" uniqKey="Lai S" first="Szu-Chia" last="Lai">Szu-Chia Lai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Preventive Medicine, National Defense Medical Center, 90048-700, San-Hsia, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Preventive Medicine, National Defense Medical Center, 90048-700, San-Hsia, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chong, Pele Choi Sing" sort="Chong, Pele Choi Sing" uniqKey="Chong P" first="Pele Choi-Sing" last="Chong">Pele Choi-Sing Chong</name>
</author>
<author>
<name sortKey="Yeh, Chia Tsui" sort="Yeh, Chia Tsui" uniqKey="Yeh C" first="Chia-Tsui" last="Yeh">Chia-Tsui Yeh</name>
</author>
<author>
<name sortKey="Liu, Levent Shih Jen" sort="Liu, Levent Shih Jen" uniqKey="Liu L" first="Levent Shih-Jen" last="Liu">Levent Shih-Jen Liu</name>
</author>
<author>
<name sortKey="Jan, Jia Tsrong" sort="Jan, Jia Tsrong" uniqKey="Jan J" first="Jia-Tsrong" last="Jan">Jia-Tsrong Jan</name>
</author>
<author>
<name sortKey="Chi, Hsiang Yun" sort="Chi, Hsiang Yun" uniqKey="Chi H" first="Hsiang-Yun" last="Chi">Hsiang-Yun Chi</name>
</author>
<author>
<name sortKey="Liu, Hwan Wun" sort="Liu, Hwan Wun" uniqKey="Liu H" first="Hwan-Wun" last="Liu">Hwan-Wun Liu</name>
</author>
<author>
<name sortKey="Chen, Ann" sort="Chen, Ann" uniqKey="Chen A" first="Ann" last="Chen">Ann Chen</name>
</author>
<author>
<name sortKey="Wang, Yeau Ching" sort="Wang, Yeau Ching" uniqKey="Wang Y" first="Yeau-Ching" last="Wang">Yeau-Ching Wang</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:16132115</idno>
<idno type="pmid">16132115</idno>
<idno type="doi">10.1007/s11373-005-9004-3</idno>
<idno type="wicri:Area/PubMed/Corpus">002562</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002562</idno>
<idno type="wicri:Area/PubMed/Curation">002562</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002562</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002800</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002800</idno>
<idno type="wicri:Area/Ncbi/Merge">001139</idno>
<idno type="wicri:Area/Ncbi/Curation">001139</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001139</idno>
<idno type="wicri:doubleKey">1021-7770:2005:Lai S:characterization:of:neutralizing</idno>
<idno type="wicri:Area/Main/Merge">004C22</idno>
<idno type="wicri:Area/Main/Curation">004905</idno>
<idno type="wicri:Area/Main/Exploration">004905</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).</title>
<author>
<name sortKey="Lai, Szu Chia" sort="Lai, Szu Chia" uniqKey="Lai S" first="Szu-Chia" last="Lai">Szu-Chia Lai</name>
<affiliation wicri:level="1">
<nlm:affiliation>Institute of Preventive Medicine, National Defense Medical Center, 90048-700, San-Hsia, Taipei, Taiwan.</nlm:affiliation>
<country xml:lang="fr">Taïwan</country>
<wicri:regionArea>Institute of Preventive Medicine, National Defense Medical Center, 90048-700, San-Hsia, Taipei</wicri:regionArea>
<wicri:noRegion>Taipei</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chong, Pele Choi Sing" sort="Chong, Pele Choi Sing" uniqKey="Chong P" first="Pele Choi-Sing" last="Chong">Pele Choi-Sing Chong</name>
</author>
<author>
<name sortKey="Yeh, Chia Tsui" sort="Yeh, Chia Tsui" uniqKey="Yeh C" first="Chia-Tsui" last="Yeh">Chia-Tsui Yeh</name>
</author>
<author>
<name sortKey="Liu, Levent Shih Jen" sort="Liu, Levent Shih Jen" uniqKey="Liu L" first="Levent Shih-Jen" last="Liu">Levent Shih-Jen Liu</name>
</author>
<author>
<name sortKey="Jan, Jia Tsrong" sort="Jan, Jia Tsrong" uniqKey="Jan J" first="Jia-Tsrong" last="Jan">Jia-Tsrong Jan</name>
</author>
<author>
<name sortKey="Chi, Hsiang Yun" sort="Chi, Hsiang Yun" uniqKey="Chi H" first="Hsiang-Yun" last="Chi">Hsiang-Yun Chi</name>
</author>
<author>
<name sortKey="Liu, Hwan Wun" sort="Liu, Hwan Wun" uniqKey="Liu H" first="Hwan-Wun" last="Liu">Hwan-Wun Liu</name>
</author>
<author>
<name sortKey="Chen, Ann" sort="Chen, Ann" uniqKey="Chen A" first="Ann" last="Chen">Ann Chen</name>
</author>
<author>
<name sortKey="Wang, Yeau Ching" sort="Wang, Yeau Ching" uniqKey="Wang Y" first="Yeau-Ching" last="Wang">Yeau-Ching Wang</name>
</author>
</analytic>
<series>
<title level="j">Journal of biomedical science</title>
<idno type="ISSN">1021-7770</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Antibodies, Monoclonal (chemistry)</term>
<term>Antibodies, Monoclonal (immunology)</term>
<term>Base Sequence</term>
<term>Blotting, Western</term>
<term>DNA Primers</term>
<term>Electrophoretic Mobility Shift Assay</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Epitopes (chemistry)</term>
<term>Epitopes (immunology)</term>
<term>Fluorescent Antibody Technique, Indirect</term>
<term>Membrane Glycoproteins (chemistry)</term>
<term>Membrane Glycoproteins (immunology)</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Molecular Sequence Data</term>
<term>Neutralization Tests</term>
<term>SARS Virus (immunology)</term>
<term>Spike Glycoprotein, Coronavirus</term>
<term>Viral Envelope Proteins (chemistry)</term>
<term>Viral Envelope Proteins (immunology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Amorces ADN</term>
<term>Animaux</term>
<term>Anticorps monoclonaux ()</term>
<term>Anticorps monoclonaux (immunologie)</term>
<term>Données de séquences moléculaires</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires ()</term>
<term>Glycoprotéines membranaires (immunologie)</term>
<term>Protéines de l'enveloppe virale ()</term>
<term>Protéines de l'enveloppe virale (immunologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Séquence d'acides aminés</term>
<term>Séquence nucléotidique</term>
<term>Technique d'immunofluorescence indirecte</term>
<term>Technique de Western</term>
<term>Test ELISA</term>
<term>Test de retard de migration électrophorétique</term>
<term>Tests de neutralisation</term>
<term>Virus du SRAS (immunologie)</term>
<term>Épitopes ()</term>
<term>Épitopes (immunologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Antibodies, Monoclonal</term>
<term>Epitopes</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en">
<term>Antibodies, Monoclonal</term>
<term>Epitopes</term>
<term>Membrane Glycoproteins</term>
<term>Viral Envelope Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="immunologie" xml:lang="fr">
<term>Anticorps monoclonaux</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Virus du SRAS</term>
<term>Épitopes</term>
</keywords>
<keywords scheme="MESH" qualifier="immunology" xml:lang="en">
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Base Sequence</term>
<term>Blotting, Western</term>
<term>DNA Primers</term>
<term>Electrophoretic Mobility Shift Assay</term>
<term>Enzyme-Linked Immunosorbent Assay</term>
<term>Fluorescent Antibody Technique, Indirect</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Molecular Sequence Data</term>
<term>Neutralization Tests</term>
<term>Spike Glycoprotein, Coronavirus</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Amorces ADN</term>
<term>Animaux</term>
<term>Anticorps monoclonaux</term>
<term>Données de séquences moléculaires</term>
<term>Glycoprotéine de spicule des coronavirus</term>
<term>Glycoprotéines membranaires</term>
<term>Protéines de l'enveloppe virale</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Séquence d'acides aminés</term>
<term>Séquence nucléotidique</term>
<term>Technique d'immunofluorescence indirecte</term>
<term>Technique de Western</term>
<term>Test ELISA</term>
<term>Test de retard de migration électrophorétique</term>
<term>Tests de neutralisation</term>
<term>Épitopes</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The spike (S) glycoprotein is thought to play a complex and central role in the biology and pathogenesis of SARS coronavirus infection. In this study, a recombinant protein (rS268, corresponding to residues 268-1255 of SARS-CoV S protein) was expressed in Escherichia coli and was purified to near homogeneity. After immunization with rS268, S protein-specific BALB/c antisera and mAbs were induced and confirmed using ELISA, Western blot and IFA. Several BALB/c mAbs were found to be effectively to neutralize the infection of Vero E6 cells by SARS-CoV in a dose-dependent manner. Systematic epitope mapping showed that all these neutralizing mAbs recognized a 15-residues peptide (CB-119) corresponding to residues 1143-1157 (SPDVDLGDISGINAS) that was located to the second heptad repeat (HR2) region of the SARS-CoV spike protein. The peptide CB-119 could specifically inhibit the interaction of neutralizing mAbs and spike protein in a dose-dependent manner. Further, neutralizing mAbs, but not control mAbs, could specifically interact with CB-119 in a dose-dependent manner. Results implicated that the second heptad repeat region of spike protein could be a good target for vaccine development against SARS-CoV.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Taïwan</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Chen, Ann" sort="Chen, Ann" uniqKey="Chen A" first="Ann" last="Chen">Ann Chen</name>
<name sortKey="Chi, Hsiang Yun" sort="Chi, Hsiang Yun" uniqKey="Chi H" first="Hsiang-Yun" last="Chi">Hsiang-Yun Chi</name>
<name sortKey="Chong, Pele Choi Sing" sort="Chong, Pele Choi Sing" uniqKey="Chong P" first="Pele Choi-Sing" last="Chong">Pele Choi-Sing Chong</name>
<name sortKey="Jan, Jia Tsrong" sort="Jan, Jia Tsrong" uniqKey="Jan J" first="Jia-Tsrong" last="Jan">Jia-Tsrong Jan</name>
<name sortKey="Liu, Hwan Wun" sort="Liu, Hwan Wun" uniqKey="Liu H" first="Hwan-Wun" last="Liu">Hwan-Wun Liu</name>
<name sortKey="Liu, Levent Shih Jen" sort="Liu, Levent Shih Jen" uniqKey="Liu L" first="Levent Shih-Jen" last="Liu">Levent Shih-Jen Liu</name>
<name sortKey="Wang, Yeau Ching" sort="Wang, Yeau Ching" uniqKey="Wang Y" first="Yeau-Ching" last="Wang">Yeau-Ching Wang</name>
<name sortKey="Yeh, Chia Tsui" sort="Yeh, Chia Tsui" uniqKey="Yeh C" first="Chia-Tsui" last="Yeh">Chia-Tsui Yeh</name>
</noCountry>
<country name="Taïwan">
<noRegion>
<name sortKey="Lai, Szu Chia" sort="Lai, Szu Chia" uniqKey="Lai S" first="Szu-Chia" last="Lai">Szu-Chia Lai</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004905 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004905 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:16132115
   |texte=   Characterization of neutralizing monoclonal antibodies recognizing a 15-residues epitope on the spike protein HR2 region of severe acute respiratory syndrome coronavirus (SARS-CoV).
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:16132115" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021